Myelinating Oligodendrocytes
<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Myelinating Oligodendrocytes</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Glia > Oligodendrocyte > Myelinating</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>MBP, PLP1, MOG, CNP, MAG</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>White Matter, Gray Matter, Subcortical</td>
</tr>
<tr>
<td class="label">Disease Vulnerability</td>
<td>MS, AD, PD, ALS, Huntington's</td>
</tr>
</table>
Myelinating Oligodendrocytes
Introduction
Myelinating oligodendrocytes are the mature, myelin-producing cells of the central nervous system (CNS). Each oligodendrocyte can myelinate up to 60 axonal segments, forming the essential electrical insulation that enables rapid saltatory conduction of action potentials[@baumann2001][@nave2014].
Overview
...Myelinating Oligodendrocytes
<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Myelinating Oligodendrocytes</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Glia > Oligodendrocyte > Myelinating</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>MBP, PLP1, MOG, CNP, MAG</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>White Matter, Gray Matter, Subcortical</td>
</tr>
<tr>
<td class="label">Disease Vulnerability</td>
<td>MS, AD, PD, ALS, Huntington's</td>
</tr>
</table>
Myelinating Oligodendrocytes
Introduction
Myelinating oligodendrocytes are the mature, myelin-producing cells of the central nervous system (CNS). Each oligodendrocyte can myelinate up to 60 axonal segments, forming the essential electrical insulation that enables rapid saltatory conduction of action potentials[@baumann2001][@nave2014].
Overview
Mermaid diagram (expand to render)
Myelinating Oligodendrocytes are a specialized cell type classified within the Glia > Oligodendrocyte > Myelinating pathway. These cells are primarily found in White Matter, gray matter, and subcortical regions, characterized by expression of marker genes including MBP, PLP1, MOG, CNP, and MAG. They are selectively vulnerable or involved in multiple sclerosis, Alzheimer's disease, Parkinson's disease, ALS, and Huntington's disease["@simons2015"].
<!-- taxonomy-enrichment -->
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
| Taxonomy | ID | Name / Label |
|----------|----|---------------|
| Cell Ontology (CL) | [CL:4023154](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023154) | myelinating glial cell |
Morphology & Electrophysiology
- Morphology: myelinating glial cell (source: Cell Ontology)
- Morphology can be inferred from Cell Ontology classification
PanglaoDB Marker Cross-References
External Database Links
- [Cell Ontology (CL:4023154)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023154)
- [OBO Foundry (CL:4023154)](http://purl.obolibrary.org/obo/CL_4023154)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [Human Cell Atlas](https://www.humancellatlas.org/)
- [PanglaoDB](https://panglaodb.se/)
Taxonomy & Classification
| Database | ID | Name | Confidence |
|----------|----|------|------------|
| Cell Ontology | [CL:4023154](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023154) | myelinating glial cell | Medium |
PanglaoDB Marker Cross-References
External Database Links
- [Cell Ontology (CL:4023154)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023154)
- [OBO Foundry (CL:4023154)](http://purl.obolibrary.org/obo/CL_4023154)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [PanglaoDB](https://panglaodb.se/)
Morphology and Myelin Structure
Cellular Architecture
Myelinating oligodendrocytes possess distinct morphological features:
- Cell body: Located in gray or white matter, typically 10-20 micrometers in diameter
- Primary processes: Extend from cell body toward axon tracts
- Myelin sheets: Flat, lamellar processes that wrap around axons
- Internodes: Myelinated segments between nodes of Ranvier
- Paranodal loops: Specializations at axon-glial junctions
Myelin Composition
The myelin sheath is composed of lipids and proteins:
| Component | Percentage | Function |
|-----------|-------------|----------|
| Lipids | 70-85% | Insulation, membrane structure |
| Proteins | 15-30% | Myelin stability, adhesion |
| MBP | 30% of protein | Myelin compaction |
| PLP1 | 50% of protein | Myelin integrity |
| MOG | 0.1% of protein | Surface recognition |
Normal Function
Saltatory Conduction
Myelinating oligodendrocytes enable rapid nerve impulse transmission:
Action potentials propagate through nodes of Ranvier
Myelin sheaths insulate internodal segments
Currents passively flow along myelinated axons
Nodes regenerate action potentials at regular intervals
Conduction velocity increases 10-50x vs unmyelinated axonsOligodendrocytes provide metabolic support to axons:
- Lactate shuttle: Supplies energy substrates to axons
- Glutamate recycling: Clears extracellular glutamate
- Ion homeostasis: Maintains ionic balance
Axonal Protection
Myelination provides structural and functional protection:
- Physical barrier to external insults
- Prevention of axonal degeneration
- Support for axonal transport
Role in Disease
Multiple Sclerosis
In MS, myelin loss is the hallmark pathological feature:
- Demyelination: Immune-mediated attack on oligodendrocytes
- Remyelination failure: OPCs fail to differentiate
- Axonal transection: Secondary axonal loss
- Neurodegeneration: Progressive disability
White Matter Changes in AD
Alzheimer's disease involves white matter abnormalities:
- Reduced myelin density in early stages
- Oligodendrocyte apoptosis
- Disrupted myelination timing
- Correlation with cognitive decline
PD and Myelin
Parkinson's disease shows:
- Reduced myelin in substantia nigra
- Oligodendrocyte loss in premium regions
- Relationship to dopaminergic neuron vulnerability
ALS
Amyotrophic lateral sclerosis features:
- Oligodendrocyte death in spinal cord
- Reduced myelin basic protein
- Failed regeneration capacity
Therapeutic Implications
Remyelination Strategies
| Approach | Target | Status |
|----------|-------|--------|
| Anti-LINGO-1 (Opicinumab) | LINGO-1 receptor | Phase 2 |
| Clemastine | M1 muscarinic receptor | Phase 2 |
| Pseudophosphorylation MBP | MBP function | Preclinical |
| OPC transplantation | Cell replacement | Phase 1 |
Neuroprotection
- Minocycline: Microglial inhibition
- Clemastine: OPC maturation
- mTOR activation: Myelin regeneration
See Also
- [Cell Types Index](/cell-types)
- [Oligodendrocyte Precursor Cells
- [Regenerating Oligodendrocytes](/cell-types/regenerating-oligodendrocytes)
- Diseases Index](/diseases/oligodendrocyte-precursor-cells
--regenerating-oligodendrocytes
--diseases-index)
- [Mechanisms Index](/mechanisms)
- [Multiple Sclerosis](/diseases/multiple-sclerosis)
- [Myelin](/mechanisms/myelin-integrity)
Pathway Diagram
The following diagram shows the key molecular relationships involving Myelinating Oligodendrocytes discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)